CARA

Cara Therapeutics develops therapeutics to treat human diseases associated with pain and inflammation.

Business Model:

Revenue: $39.4M

Employees: 51-200

Detailed CARA Information

Geographic Data

CARA headquarters map

Address: 4 Stamford Plaza 107 Elm Street

City: Stamford

State: CT

Zip: 06902

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$146M

Raised Total:

$472M

Metrics

4,841,250Website Global Rank

1,848Website Monthly Traffic

Twitter Followers

Description

Cara Therapeutics develops therapeutics to treat human diseases associated with pain and inflammation.

Contact Phone:
+12034063700

Contact Email:

CARA went public on 1/31/2014 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
1/31/2014

IPO Valuation:
$262M

Ticker Symbol:
CARA

IPO Price:
$11/share

Amount Raised:
$55M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
7/2019 Post-IPO Equity $145.5M
7/2015 Post-IPO Equity $80.5M
3/2017 Post-IPO Equity $92.1M
11/2006 Series C 5 $24M Alta Partners
MVM Life Science Partners
Scottish Widows Investment Partnership
Mitsubishi UFJ Capital
Ascent Biomedical Ventures
Alta Partners
MVM Life Science Partners
7/2010 Series D $0 Devon Park BioVentures
Mitsubishi Corporation
MVM Life Science Partners
Connecticut Innovations
Scottish Widows Investment Partnership
Ascent Biomedical Ventures
Alta Partners
Rho Capital Partners
Rho Capital Partners
Devon Park BioVentures
Mitsubishi Corporation
MVM Life Science Partners
Connecticut Innovations
Scottish Widows Investment Partnership
Ascent Biomedical Ventures
Alta Partners
Rho Capital Partners
Rho Capital Partners
12/2005 Series B 2 $4.7M Esperante Ventures
Ascent Biomedical Ventures
7/2008 Series C $0 Connecticut Innovations
Devon Park BioVentures
Devon Park BioVentures
Ascent Biomedical Ventures
Mitsubishi International Corporation (MIC)
Connecticut Innovations
Devon Park BioVentures
Devon Park BioVentures
Ascent Biomedical Ventures
Mitsubishi International Corporation (MIC)
7/2019 Post-IPO Equity $145M
2/2014 Post-IPO Equity $55.9M
7/2018 Post-IPO Equity $98.3M
8/2015 Post-IPO Equity $80.5M
7/2010 Series D 8 $15M Devon Park BioVentures
Mitsubishi Corporation
MVM Life Science Partners
Connecticut Innovations
Scottish Widows Investment Partnership
Ascent Biomedical Ventures
Alta Partners
Rho Capital Partners
Rho Capital Partners
Devon Park BioVentures
Mitsubishi Corporation
MVM Life Science Partners
Connecticut Innovations
Scottish Widows Investment Partnership
Ascent Biomedical Ventures
Alta Partners
Rho Capital Partners
Rho Capital Partners
7/2008 Series C 4 $12.3M Connecticut Innovations
Devon Park BioVentures
Devon Park BioVentures
Connecticut Innovations
Devon Park BioVentures
Devon Park BioVentures
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research